EQT’s IVC Evidensia spends £34m on UK regulatory probe

EQT’s veterinary group IVC Evidensia has spent £34 million over the past two years addressing a probe by the UK Competition and Markets Authority, as revealed in newly filed accounts. This substantial expenditure underscores the intense scrutiny faced by the company, likely related to concerns over market competition and pricing practices within the veterinary sector. The investigation’s outcome could have significant implications for IVC Evidensia’s business operations and its standing in the industry, highlighting the broader impact of regulatory investigations on private equity-backed firms.